A detailed history of Terrapin Asset Management, LLC transactions in Avrobio, Inc. stock. As of the latest transaction made, Terrapin Asset Management, LLC holds 558,787 shares of AVRO stock, worth $0. This represents 0.98% of its overall portfolio holdings.

Number of Shares
558,787
Holding current value
$0
% of portfolio
0.98%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.98 - $1.62 $547,611 - $905,234
558,787 New
558,787 $861 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Terrapin Asset Management, LLC Portfolio

Follow Terrapin Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terrapin Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Terrapin Asset Management, LLC with notifications on news.